Clinical Trials on Orális szubmukózus fibrózis
Total 4838 results
-
Bristol-Myers SquibbCompletedIdiopathic Pulmonary FibrosisUnited States, Mexico, Australia, Colombia, Chile, Peru
-
NYU Langone HealthStony Brook University; National Center for Research Resources (NCRR); Philips...CompletedPulmonary FibrosisUnited States
-
GlaxoSmithKlineCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisSpain, United Kingdom, Italy, Belgium, Germany, Netherlands, Finland, Denmark
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisItaly
-
University Hospital, GrenobleCompletedIdiopathic Pulmonary FibrosisFrance
-
Boehringer IngelheimCompleted
-
patientMpower Ltd.Health Service Executive, IrelandCompletedIdiopathic Pulmonary FibrosisIreland
-
Gilead SciencesTerminatedLiver Fibrosis Due to NASHUnited States, Canada, France, Italy, Germany, Puerto Rico, Spain, United Kingdom
-
Boehringer IngelheimNo longer availableIdiopathic Pulmonary FibrosisBrazil
-
Asahi Kasei Pharma CorporationCompletedIdiopathic Pulmonary FibrosisJapan
-
GlaxoSmithKlineTerminatedIdiopathic Pulmonary FibrosisUnited Kingdom
-
University of AarhusEurostarsUnknownFeasibility & Effect of a Tele-rehabilitation Program in Idiopathic Pulmonary Fibrosis (IPF) (3-IPF)Idiopathic Pulmonary FibrosisDenmark
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisCanada, United States, Netherlands, France, Italy, Germany
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomCompleted
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI); University of Chicago; Columbia... and other collaboratorsCompletedIdiopathic Pulmonary FibrosisUnited States
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Israel, Australia, Italy, Canada, United Kingdom, Switzerland, Germany, Poland, Czechia, Belgium, France
-
Genentech, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisGermany, United Kingdom, Ireland, France, Austria, Denmark, Finland, Italy, Norway, Sweden
-
Genentech, Inc.CompletedIdiopathic Pulmonary Fibrosis | Pulmonary FibrosisUnited States
-
Genentech, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Hoffmann-La RocheInterMune Deutschland GmbHCompletedIdiopathic Pulmonary FibrosisGermany
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Australia, Canada, Czech Republic, Germany, Ireland, Israel, Italy, Switzerland
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Netherlands, Japan, Germany, Czech Republic, Italy, Switzerland, Austria, Croatia, Ireland, Israel, Serbia
-
Genentech, Inc.Approved for marketingIdiopathic Pulmonary Fibrosis
-
Genzyme, a Sanofi CompanyCompletedIdiopathic Pulmonary FibrosisUnited States, Belgium
-
US Department of Veterans AffairsCompletedIdiopathic Pulmonary FibrosisUnited States
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); Duke Clinical Research InstituteTerminatedIdiopathic Pulmonary FibrosisUnited States
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, Israel, Spain, Australia, France, Canada, Turkey, Germany, Italy, South Africa, Slovenia, Sweden
-
ImmuneWorksCompletedIdiopathic Pulmonary FibrosisUnited States
-
Institut National de la Santé Et de la Recherche...CompletedIdiopathic Pulmonary Fibrosis
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, United Kingdom, Switzerland, Israel, Canada, France, Germany, Italy
-
Rabin Medical CenterUnknownIdiopathic Pulmonary FibrosisIsrael
-
InterMuneCompletedIdiopathic Pulmonary FibrosisUnited States
-
Virginia Commonwealth UniversityWake Forest UniversityRecruitingMyocardial Fibrosis | Myocardial Injury | Chemotherapeutic ToxicityUnited States
-
4D Molecular TherapeuticsRecruiting
-
Jianwu DaiSouthwest Hospital, ChinaCompletedPost-radiotherapy Pulmonary FibrosisChina
-
Hospices Civils de LyonRecruitingProgressive Idiopathic Pulmonary FibrosisFrance
-
University Hospital, GrenobleUnknownCystic Fibrosis Pulmonary ExacerbationFrance
-
Unity Health TorontoSunnybrook Health Sciences Centre; University of TorontoTerminatedCystic Fibrosis Pulmonary ExacerbationCanada
-
Cedars-Sinai Medical CenterGenentech, Inc.Recruiting
-
Blade TherapeuticsNot yet recruitingRESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary Fibrosis
-
University Hospital, ToursInstitut National de la Santé Et de la Recherche Médicale, FranceRecruitingIdiopathic Pulmonary FibrosisFrance
-
Novartis PharmaceuticalsTerminatedIdiopathic Pulmonary FibrosisUnited States, Germany, Italy, Canada, Ireland, United Kingdom
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisGreece
-
Assistance Publique - Hôpitaux de ParisCompletedIdiopathic Pulmonary FibrosisFrance
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Netherlands, Italy, Germany, Switzerland, Czechia, Spain
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Belgium, Australia, United Kingdom, Canada, China, Germany, Japan, Turkey, France, Ireland, Italy, Israel, Netherlands, Portugal, Greece, India, Czechia, Chile, Finland, Mexico, Russian Federation
-
Belgian Thoracic SocietyBoehringer Ingelheim; Roche Farma, S.ACompletedIdiopathic Pulmonary FibrosisBelgium, Luxembourg